BR112021016996A2 - - Google Patents

Info

Publication number
BR112021016996A2
BR112021016996A2 BR112021016996A BR112021016996A BR112021016996A2 BR 112021016996 A2 BR112021016996 A2 BR 112021016996A2 BR 112021016996 A BR112021016996 A BR 112021016996A BR 112021016996 A BR112021016996 A BR 112021016996A BR 112021016996 A2 BR112021016996 A2 BR 112021016996A2
Authority
BR
Brazil
Application number
BR112021016996A
Other languages
Portuguese (pt)
Other versions
BR112021016996A8 (pt
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from KR1020200023629A external-priority patent/KR102368983B1/ko
Application filed filed Critical
Publication of BR112021016996A2 publication Critical patent/BR112021016996A2/pt
Publication of BR112021016996A8 publication Critical patent/BR112021016996A8/pt

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K7/00Peptides having 5 to 20 amino acids in a fully defined sequence; Derivatives thereof
    • C07K7/04Linear peptides containing only normal peptide links
    • C07K7/06Linear peptides containing only normal peptide links having 5 to 11 amino acids
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04Antibacterial agents
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K7/00Peptides having 5 to 20 amino acids in a fully defined sequence; Derivatives thereof
    • C07K7/04Linear peptides containing only normal peptide links
    • C07K7/08Linear peptides containing only normal peptide links having 12 to 20 amino acids
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12NMICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N9/00Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
    • C12N9/10Transferases (2.)
    • C12N9/12Transferases (2.) transferring phosphorus containing groups, e.g. kinases (2.7)
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00Medicinal preparations containing peptides
    • YGENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02ATECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
    • Y02A50/00TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
    • Y02A50/30Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change

Landscapes

  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Genetics & Genomics (AREA)
  • Molecular Biology (AREA)
  • Biochemistry (AREA)
  • Biophysics (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Oncology (AREA)
  • Communicable Diseases (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Wood Science & Technology (AREA)
  • Zoology (AREA)
  • Biomedical Technology (AREA)
  • Biotechnology (AREA)
  • Microbiology (AREA)
  • General Engineering & Computer Science (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Peptides Or Proteins (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Cosmetics (AREA)
  • Coloring Foods And Improving Nutritive Qualities (AREA)
BR112021016996A 2019-02-28 2020-02-27 Polipeptídeo com atividade antibacteriana, composição para prevenir ou tratar sepsis compreendendo a mesma e composição antibacteriana BR112021016996A8 (pt)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
KR20190023534 2019-02-28
KR1020200023629A KR102368983B1 (ko) 2019-02-28 2020-02-26 항균활성을 갖는 폴리펩타이드, 이를 포함하는 패혈증 예방 또는 치료용 조성물, 및 항균용 조성물
PCT/KR2020/002826 WO2020175936A1 (ko) 2019-02-28 2020-02-27 항균활성을 갖는 폴리펩타이드, 이를 포함하는 패혈증 예방 또는 치료용 조성물, 및 항균용 조성물

Publications (2)

Publication Number Publication Date
BR112021016996A2 true BR112021016996A2 (en:Method) 2021-11-30
BR112021016996A8 BR112021016996A8 (pt) 2022-11-22

Family

ID=72239598

Family Applications (1)

Application Number Title Priority Date Filing Date
BR112021016996A BR112021016996A8 (pt) 2019-02-28 2020-02-27 Polipeptídeo com atividade antibacteriana, composição para prevenir ou tratar sepsis compreendendo a mesma e composição antibacteriana

Country Status (5)

Country Link
US (1) US12371453B2 (en:Method)
JP (1) JP7219512B2 (en:Method)
BR (1) BR112021016996A8 (en:Method)
CA (1) CA3168643A1 (en:Method)
WO (1) WO2020175936A1 (en:Method)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN115960171B (zh) * 2022-10-12 2023-08-29 东北农业大学 高稳定性Trp-pocket跨链交互型β-发卡抗菌肽及制备方法和应用
CN118406113B (zh) * 2024-05-10 2025-04-22 东北农业大学 具有lps结合能力的靶向革兰氏阴性菌的抗菌肽及其制备方法和应用
CN118955633B (zh) * 2024-07-19 2025-05-09 东北农业大学 富含D-Arg的抗酶解十四肽2rrr及其制备方法和应用
CN119591691A (zh) * 2025-01-10 2025-03-11 福建农林大学 基于大黄鱼cxcl8蛋白的抗菌肽及其应用

Family Cites Families (17)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7608277B2 (en) * 2004-12-01 2009-10-27 Gene Therapy Systems, Inc. Tuberculosis nucleic acids, polypeptides and immunogenic compositions
EP2214656B1 (en) * 2007-10-26 2018-12-05 Avivagen Inc. Compositions and methods for enhancing immune response
EP2344178B1 (en) 2008-10-05 2014-12-03 Universita Degli Studi di Siena Peptide sequences, their branched form and use thereof for antimicrobial applications
EA201891284A1 (ru) * 2011-05-20 2018-11-30 Олдербайо Холдингз Ллк Композиции антител против cgrp и их применение
DK3403669T3 (da) * 2011-06-19 2020-08-24 Univ New York Fremgangsmåder til behandling og forebyggelse af staphylococcus aureus-infektioner og forbundne tilstande
RU2732378C2 (ru) 2014-01-29 2020-09-16 Энзиматика Аб Новые виды лечения
JP6338899B2 (ja) 2014-03-18 2018-06-06 国立研究開発法人産業技術総合研究所 両生類ネッタイツメガエル皮膚由来機能性ペプチド
KR101477795B1 (ko) 2014-04-23 2015-01-02 건국대학교 산학협력단 Adk 단백질을 유효성분으로 포함하는 패혈증 또는 패혈증성 쇼크의 예방 또는 치료용 조성물
KR101785050B1 (ko) 2014-12-10 2017-10-13 건국대학교 글로컬산학협력단 Adk 단백질 및 항생제를 유효성분으로 포함하는 패혈증 또는 패혈증성 쇼크의 예방 또는 치료용 조성물
US10792340B2 (en) 2015-04-03 2020-10-06 Konkuk University Glocal Industry-Academic Collaboration Foundation Antibacterial composition for combating carbapenem-resistant gram-negative bacteria comprising ADK protein as active ingredient
CN109415411B (zh) 2015-09-17 2022-06-28 首尔大学校产学协力团 表现出抗革兰氏阴性菌的抗微生物活性的断开或折叠的螺旋肽或肽类似物及其用途
KR101792239B1 (ko) * 2016-11-01 2017-10-31 경북대학교 산학협력단 7,10-에폭시옥타데카-7,9-다이에노산 및 항생제를 유효성분으로 포함하는 항균 조성물
CN110753724B (zh) 2017-06-16 2022-05-10 博里利斯股份公司 用于光伏应用的聚合物组合物
EP3641746B1 (en) * 2017-06-19 2024-11-20 President And Fellows Of Harvard College Methods and compositions for treating a microbial infection
KR102011676B1 (ko) 2017-08-29 2019-08-19 (주) 한성스틸 벽난로
WO2021187928A1 (ko) 2020-03-20 2021-09-23 단디바이오사이언스 주식회사 리포폴리사카라이드 제거용 조성물 및 키트
KR102709142B1 (ko) * 2020-08-27 2024-09-26 에이치엘비사이언스 주식회사 알츠하이머 치매 예방 또는 치료용 펩타이드 조성물

Also Published As

Publication number Publication date
BR112021016996A8 (pt) 2022-11-22
US20220144892A1 (en) 2022-05-12
WO2020175936A1 (ko) 2020-09-03
JP2022521543A (ja) 2022-04-08
US12371453B2 (en) 2025-07-29
JP7219512B2 (ja) 2023-02-08
CA3168643A1 (en) 2020-09-03

Similar Documents

Publication Publication Date Title
BR112019017762A2 (en:Method)
BR112021017339A2 (en:Method)
BR112021017637A2 (en:Method)
BR112021017939A2 (en:Method)
BR112021017892A2 (en:Method)
BR112019016141A2 (en:Method)
BR112021017738A2 (en:Method)
BR112021017782A2 (en:Method)
BR112021008711A2 (en:Method)
BR112021016821A2 (en:Method)
BR112021018452A2 (en:Method)
BR112021017728A2 (en:Method)
AU2020104490A5 (en:Method)
BR112019016142A2 (en:Method)
BR112019016138A2 (en:Method)
BR112021017234A2 (en:Method)
BR112021018168A2 (en:Method)
BR112021017703A2 (en:Method)
BR112021016996A2 (en:Method)
BR112021017732A2 (en:Method)
BR112021015080A2 (en:Method)
BR112021012348A2 (en:Method)
BR112021017355A2 (en:Method)
BR112021018093A2 (en:Method)
BR112021017173A2 (en:Method)

Legal Events

Date Code Title Description
B25D Requested change of name of applicant approved

Owner name: HLB SCIENCE INC. (KR)

B25G Requested change of headquarter approved

Owner name: HLB SCIENCE INC. (KR)